Apoptosis in right-ventricle biopsy is not predictive of graft survival

L Chalabreysse1, C Leroux, J-F Obadia

  • 1Department of Pathology, Hôpital Louis Pradel, BP Lyon Montchat 69 394, Cedex 03 Lyon, France. lara.chalabreysse@chu-lyon.fr

Insights

Brain death can cause cell death in donor hearts, but this pre-existing apoptosis does not predict heart transplant dysfunction. Researchers examined donor and control hearts for signs of cell death to understand transplant outcomes.

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Cell Biology

Background:

  • Myocardial dysfunction is a frequent complication in heart grafts from brain-dead donors.
  • The underlying mechanisms contributing to this dysfunction are not fully understood.
  • Apoptosis (programmed cell death) has been proposed as a potential factor.

Purpose of the Study:

  • To investigate the presence of apoptotic myocardial cells in brain-dead donor hearts.
  • To compare apoptosis levels in donor hearts versus control hearts.
  • To determine if pre-existing apoptosis in donor hearts predicts post-transplant myocardial dysfunction.

Main Methods:

  • Apoptosis was assessed using an in situ DNA fragmentation assay.
  • Western Blotting was employed to detect caspase-3, a key enzyme in the apoptotic pathway.
  • Donor hearts were compared to control hearts.

Main Results:

  • Brain death was found to induce myocardial apoptosis in donor hearts.
  • However, the levels of apoptosis detected in donor hearts did not correlate with the development of myocardial dysfunction after transplantation.
  • Caspase-3 activation was observed, confirming apoptotic activity.

Conclusions:

  • Myocardial apoptosis induced by brain death is present in donor hearts.
  • Pre-existing apoptosis in donor hearts is not a reliable predictor of myocardial dysfunction following heart transplantation.
  • Further research is needed to identify the precise mechanisms of graft dysfunction.

Related Concept Videos